In this week’s View, Dr. Eagle explores the use of high-sensitivity cardiac troponin for risk assessment in patients with chronic coronary artery disease. He then explores the potential of using low-dose colchicine for secondary prevention of coronary artery disease. Finally, Dr. Eagle looks at the use of beta-blockers and heart failure outcomes in patients with mildly reduced or preserved ejection fraction.

Subscribe to Eagle’s Eye View